Yoshinobu Maeda

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Motoko Yamaguchi, Yok‐Lam Kwong, Won Seog Kim et al. · Journal of Clinical Oncology · 2011 · 596 citations

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

Seok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard et al. · The Lancet Oncology · 2016 · 375 citations · Full text

Lymphoid Neoplasia, Oncology, Retrospective Analysis +7

Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in mice

Pavan Reddy, Yaping Sun, Tomomi Toubai et al. · Journal of Clinical Investigation · 2008 · 267 citations · Full text

Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect

Pavan Reddy, Yoshinobu Maeda, Kevin B. Hotary et al. · Proceedings of the National Academy of Sciences · 2004 · 266 citations · Full text

Host Dendritic Cells Alone Are Sufficient to Initiate Acute Graft-versus-Host Disease

Ulrich Duffner, Yoshinobu Maeda, Kenneth R. Cooke et al. · The Journal of Immunology · 2004 · 239 citations